117145
Research payments
$1,918,967
Through program year 2025, $1,918,967 in research payments was reported against 117145, across 338 payments, paid by Iovance Biotherapeutics, Inc..
- Paid by
- Iovance Biotherapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,043,287 | 203 |
| 2024 | Research | $875,680 | 135 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gino In Los Angeles, CA Named on 57 payments
- Yazan Samhouri Pittsburgh, PA Named on 27 payments
- Melissa Wilson Easton, PA Named on 25 payments
- Juan Varela Orlando, FL Named on 24 payments
- Gary Doolittle Westwood, KS Named on 20 payments
- Thomas Curley Pittsburgh, PA Named on 18 payments
- Young Hong Camden, NJ Named on 18 payments
- Philip Lammers Bartlett, TN Named on 16 payments
- John Dubay Tuscaloosa, AL Named on 15 payments
- Meredith McKean Nashville, TN Named on 14 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.